首页 > 最新文献

Value in Health最新文献

英文 中文
Beyond the Average: Modelling Individual-Specific Preferences for Ulcerative Colitis Surgery. 超越平均值:模拟溃疡性结肠炎手术的个体特定偏好。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-10 DOI: 10.1016/j.jval.2026.02.010
Nyantara Wickramasekera, Donna Rowen, Steve Brown, Arne Risa Hole

Objectives: Surgical decisions for ulcerative colitis are complex and preference-sensitive. This study aimed to assess patient preferences for surgical treatments, quantify preference heterogeneity, and examine individual-specific preferences to inform decision-making.

Methods: Patient preferences were elicited using a discrete choice experiment (DCE). A rigorous selection process involving focus groups and interviews with clinicians and patients resulted in seven key attributes. Each task included two unlabelled surgical alternatives and a medication opt-out. A D-efficient fractional factorial design was generated. The survey was pilot tested using 'think-aloud' interviews. Data were analysed using multinomial and mixed logit models, with conditional mean coefficients used to estimate individual-specific choice probabilities.

Results: Three hundred and fifty patients completed the survey. Results showed significant preference heterogeneity for most attributes. The preference for the medication opt-out revealed a multimodal conditional distribution, clustering patients who strongly preferred, were indifferent to, or disliked medication. The interaction term 'planning to have children' fully explained the preference heterogeneity in the fertility attribute. A gender interaction term showed that male patients had a stronger negative preference for a stoma. Choice probabilities showed individual differences; some patients had a 97.98% probability of preferring medication, while others had only a 0.09% probability, instead showing a high preference for surgical options.

Conclusions: This study demonstrates the value of using conditional distributions to examine preference heterogeneity. Simpler models failed to reveal the wide range of preferences present in the data. Conditional choice probabilities can be used to better understand how different patients make treatment decisions.

目的:溃疡性结肠炎的手术决定是复杂的和偏好敏感的。本研究旨在评估患者对手术治疗的偏好,量化偏好异质性,并检查个体特定偏好,为决策提供信息。方法:采用离散选择实验(DCE)诱导患者的偏好。包括焦点小组和临床医生和患者访谈在内的严格选择过程产生了七个关键属性。每个任务包括两种未标记的手术选择和一种药物选择。产生了d效率的分数因子设计。该调查采用了“有声思考”访谈的方式进行试点测试。使用多项和混合logit模型分析数据,使用条件平均系数来估计个人特定选择概率。结果:共350例患者完成调查。结果显示大多数属性的偏好异质性显著。对药物选择退出的偏好揭示了一个多模态条件分布,聚集了强烈偏好、对药物漠不关心或不喜欢药物的患者。“计划生育”一词充分解释了生育属性的偏好异质性。性别互动项显示男性患者对造口有更强的负面偏好。选择概率存在个体差异;一些患者有97.98%的可能性选择药物治疗,而另一些患者只有0.09%的可能性选择手术治疗。结论:本研究证明了使用条件分布来检验偏好异质性的价值。简单的模型无法揭示数据中存在的广泛的偏好范围。条件选择概率可以用来更好地理解不同的病人如何做出治疗决定。
{"title":"Beyond the Average: Modelling Individual-Specific Preferences for Ulcerative Colitis Surgery.","authors":"Nyantara Wickramasekera, Donna Rowen, Steve Brown, Arne Risa Hole","doi":"10.1016/j.jval.2026.02.010","DOIUrl":"https://doi.org/10.1016/j.jval.2026.02.010","url":null,"abstract":"<p><strong>Objectives: </strong>Surgical decisions for ulcerative colitis are complex and preference-sensitive. This study aimed to assess patient preferences for surgical treatments, quantify preference heterogeneity, and examine individual-specific preferences to inform decision-making.</p><p><strong>Methods: </strong>Patient preferences were elicited using a discrete choice experiment (DCE). A rigorous selection process involving focus groups and interviews with clinicians and patients resulted in seven key attributes. Each task included two unlabelled surgical alternatives and a medication opt-out. A D-efficient fractional factorial design was generated. The survey was pilot tested using 'think-aloud' interviews. Data were analysed using multinomial and mixed logit models, with conditional mean coefficients used to estimate individual-specific choice probabilities.</p><p><strong>Results: </strong>Three hundred and fifty patients completed the survey. Results showed significant preference heterogeneity for most attributes. The preference for the medication opt-out revealed a multimodal conditional distribution, clustering patients who strongly preferred, were indifferent to, or disliked medication. The interaction term 'planning to have children' fully explained the preference heterogeneity in the fertility attribute. A gender interaction term showed that male patients had a stronger negative preference for a stoma. Choice probabilities showed individual differences; some patients had a 97.98% probability of preferring medication, while others had only a 0.09% probability, instead showing a high preference for surgical options.</p><p><strong>Conclusions: </strong>This study demonstrates the value of using conditional distributions to examine preference heterogeneity. Simpler models failed to reveal the wide range of preferences present in the data. Conditional choice probabilities can be used to better understand how different patients make treatment decisions.</p>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147444715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A quantitative exploration of the performance of a potential 'health and wellbeing' visual analogue scale (EQ-HWB VAS) for the EQ-HWB-9. 对EQ-HWB-9的潜在“健康和幸福”视觉模拟量表(EQ-HWB VAS)的性能进行定量探索。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-10 DOI: 10.1016/j.jval.2026.02.013
Richard H Xu, Chenxi Yang, Fanni Rencz

Objectives: All EuroQol instruments include a visual analogue scale (VAS), except the EQ-HWB, which captures broader aspects of wellbeing beyond health, relevant to populations providing and receiving care. This study explored the performance of a potential VAS for EQ-HWB.

Methods: The EQ-HWB VAS was developed by adapting the EQ VAS from the EQ-5D-5L, replacing "health" with "health and wellbeing" and "today" with "last week" to align the recall period with EQ-HWB. A cross-sectional survey was undertaken with an age- and sex-representative sample of the Hong Kong general population (n=1,262). Descriptive characteristics, ceiling and floor, convergent and known-group validity, and explanatory power were assessed. The performance of the EQ-HWB VAS was directly compared with the EQ VAS.

Results: The mean EQ VAS and EQ-HWB VAS scores were 76.7 and 73.5 (p<0.001). The ceiling was 5.2% for the EQ VAS and 3.6% for EQ-HWB VAS. The EQ-HWB VAS showed a very strong correlation and agreement with EQ VAS. Both the EQ VAS and EQ-HWB VAS were able to distinguish between most known groups. The EQ-HWB VAS showed larger effect sizes for groups such as caregiving, perceived income level and mental health problems. EQ-HWB-9 items explained more variance in EQ-HWB VAS scores than EQ-5D-5L dimensions did in EQ VAS scores.

Conclusion: This study provides the first evidence of the measurement properties of a "health and wellbeing" VAS for EQ-HWB, demonstrating its validity. Further research is recommended in different languages and countries to inform decisions about the addition of a VAS to the EQ-HWB.

目的:除EQ-HWB外,所有EuroQol工具都包括视觉模拟量表(VAS),该量表捕获了健康以外与提供和接受护理的人群相关的更广泛的福祉方面。本研究探讨了一个潜在的VAS对EQ-HWB的性能。方法:EQ- hwb VAS是在EQ- 5d - 5l的基础上改编而成,将“健康”替换为“健康与幸福”,将“今天”替换为“上周”,使回忆期与EQ- hwb保持一致。横断面调查采用了具有年龄和性别代表性的香港普通人群样本(n=1,262)。描述性特征、上限和下限、收敛效度和已知组效度以及解释力进行了评估。EQ- hwb评分与EQ评分进行直接比较。结果:EQ VAS和EQ- hwb VAS的平均分分别为76.7分和73.5分(p)。结论:本研究首次证明了EQ- hwb“健康与幸福”VAS的测量特性,证明了其有效性。建议在不同的语言和国家进行进一步的研究,以便为在EQ-HWB中增加VAS的决定提供信息。
{"title":"A quantitative exploration of the performance of a potential 'health and wellbeing' visual analogue scale (EQ-HWB VAS) for the EQ-HWB-9.","authors":"Richard H Xu, Chenxi Yang, Fanni Rencz","doi":"10.1016/j.jval.2026.02.013","DOIUrl":"https://doi.org/10.1016/j.jval.2026.02.013","url":null,"abstract":"<p><strong>Objectives: </strong>All EuroQol instruments include a visual analogue scale (VAS), except the EQ-HWB, which captures broader aspects of wellbeing beyond health, relevant to populations providing and receiving care. This study explored the performance of a potential VAS for EQ-HWB.</p><p><strong>Methods: </strong>The EQ-HWB VAS was developed by adapting the EQ VAS from the EQ-5D-5L, replacing \"health\" with \"health and wellbeing\" and \"today\" with \"last week\" to align the recall period with EQ-HWB. A cross-sectional survey was undertaken with an age- and sex-representative sample of the Hong Kong general population (n=1,262). Descriptive characteristics, ceiling and floor, convergent and known-group validity, and explanatory power were assessed. The performance of the EQ-HWB VAS was directly compared with the EQ VAS.</p><p><strong>Results: </strong>The mean EQ VAS and EQ-HWB VAS scores were 76.7 and 73.5 (p<0.001). The ceiling was 5.2% for the EQ VAS and 3.6% for EQ-HWB VAS. The EQ-HWB VAS showed a very strong correlation and agreement with EQ VAS. Both the EQ VAS and EQ-HWB VAS were able to distinguish between most known groups. The EQ-HWB VAS showed larger effect sizes for groups such as caregiving, perceived income level and mental health problems. EQ-HWB-9 items explained more variance in EQ-HWB VAS scores than EQ-5D-5L dimensions did in EQ VAS scores.</p><p><strong>Conclusion: </strong>This study provides the first evidence of the measurement properties of a \"health and wellbeing\" VAS for EQ-HWB, demonstrating its validity. Further research is recommended in different languages and countries to inform decisions about the addition of a VAS to the EQ-HWB.</p>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147444214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare utilisation among older adults with dementia in France: A comparative analysis of a Dementia Village and traditional nursing homes. 在法国老年痴呆症患者的医疗保健利用:痴呆村和传统养老院的比较分析。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-10 DOI: 10.1016/j.jval.2026.02.011
Damien Krier, Abdelilah Abouelfath, Jérémy Jové, Hélène Amieva, Laure Carcaillon-Bentata, Jérôme Wittwer

Objective: The Dementia Village (DV) model is emerging as an alternative to traditional nursing homes (NHs) for individuals with Alzheimer's disease and related dementias. This study evaluates the impact of the French Dementia Village, Village Landais Alzheimer Henri Emmanuelli (VLAHE), on healthcare utilisation among older adults with dementia.

Methods: This study employs an indirect comparative cohort design using data from two sources: a longitudinal observational study of VLAHE residents and an ad hoc cohort from the French Nationwide claims database of NH residents. To improve comparability, the Matching-Adjusted Indirect Comparison (MAIC) method was applied. Weighted statistical tests and logistic regression models were used, yielding odds ratios with 95% confidence intervals. The outcomes analysed include hospital admission rates, hospital stay duration, mortality, and place of death over a two-year follow-up period between January 2021-December 2022.

Results: VLAHE residents had fewer hospitalisations and shorter stays (10.5 vs. 15.2 days, p = 0.0004) than comparable NH residents, particularly for acute care. Quarterly hospitalisation rates were consistently lower (6.4% vs. 11.1%), while no significant differences were found for psychiatric or rehabilitation stays. Fewer VLAHE residents died in hospital (9% vs. 31%), suggesting improved end-of-life care (OR: 5.75, 95% CI [1.75-18.90]).

Conclusions: The VLAHE model may reduce hospitalisations and enhance end-of-life care through a structured, patient-centred approach. However, due to a potential residual clinical differences between groups and limitations of the matching method, further longitudinal research is needed to confirm its effectiveness.

目的:痴呆症村(DV)模式正在兴起,以替代传统的养老院(NHs)的个人与阿尔茨海默病和相关痴呆。本研究评估了法国老年痴呆症村(Village Landais Alzheimer Henri Emmanuelli, VLAHE)对老年痴呆症患者医疗保健利用的影响。方法:本研究采用间接比较队列设计,使用来自两个来源的数据:一个是对VLAHE居民的纵向观察研究,另一个是来自法国全国NH居民索赔数据库的临时队列。为了提高可比性,采用匹配校正间接比较法(MAIC)。采用加权统计检验和逻辑回归模型,获得95%置信区间的比值比。分析的结果包括在2021年1月至2022年12月的两年随访期间的住院率、住院时间、死亡率和死亡地点。结果:与NH居民相比,VLAHE居民住院次数更少,住院时间更短(10.5天对15.2天,p = 0.0004),特别是在急性护理方面。季度住院率持续较低(6.4%对11.1%),而精神科或康复住院没有发现显著差异。较少的VLAHE居民在医院死亡(9%对31%),表明临终关怀得到改善(OR: 5.75, 95% CI[1.75-18.90])。结论:VLAHE模型可以通过结构化的、以患者为中心的方法减少住院和加强临终关怀。然而,由于组间可能存在残留的临床差异以及匹配方法的局限性,需要进一步的纵向研究来证实其有效性。
{"title":"Healthcare utilisation among older adults with dementia in France: A comparative analysis of a Dementia Village and traditional nursing homes.","authors":"Damien Krier, Abdelilah Abouelfath, Jérémy Jové, Hélène Amieva, Laure Carcaillon-Bentata, Jérôme Wittwer","doi":"10.1016/j.jval.2026.02.011","DOIUrl":"https://doi.org/10.1016/j.jval.2026.02.011","url":null,"abstract":"<p><strong>Objective: </strong>The Dementia Village (DV) model is emerging as an alternative to traditional nursing homes (NHs) for individuals with Alzheimer's disease and related dementias. This study evaluates the impact of the French Dementia Village, Village Landais Alzheimer Henri Emmanuelli (VLAHE), on healthcare utilisation among older adults with dementia.</p><p><strong>Methods: </strong>This study employs an indirect comparative cohort design using data from two sources: a longitudinal observational study of VLAHE residents and an ad hoc cohort from the French Nationwide claims database of NH residents. To improve comparability, the Matching-Adjusted Indirect Comparison (MAIC) method was applied. Weighted statistical tests and logistic regression models were used, yielding odds ratios with 95% confidence intervals. The outcomes analysed include hospital admission rates, hospital stay duration, mortality, and place of death over a two-year follow-up period between January 2021-December 2022.</p><p><strong>Results: </strong>VLAHE residents had fewer hospitalisations and shorter stays (10.5 vs. 15.2 days, p = 0.0004) than comparable NH residents, particularly for acute care. Quarterly hospitalisation rates were consistently lower (6.4% vs. 11.1%), while no significant differences were found for psychiatric or rehabilitation stays. Fewer VLAHE residents died in hospital (9% vs. 31%), suggesting improved end-of-life care (OR: 5.75, 95% CI [1.75-18.90]).</p><p><strong>Conclusions: </strong>The VLAHE model may reduce hospitalisations and enhance end-of-life care through a structured, patient-centred approach. However, due to a potential residual clinical differences between groups and limitations of the matching method, further longitudinal research is needed to confirm its effectiveness.</p>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Future Agenda for Digital Health Technologies: Evidence That Works for Decisions. 数字卫生技术的未来议程:有利于决策的证据。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-03 DOI: 10.1016/j.jval.2026.02.007
Axel Mühlbacher, Volker Amelung, Katarzyna Kolasa
{"title":"A Future Agenda for Digital Health Technologies: Evidence That Works for Decisions.","authors":"Axel Mühlbacher, Volker Amelung, Katarzyna Kolasa","doi":"10.1016/j.jval.2026.02.007","DOIUrl":"https://doi.org/10.1016/j.jval.2026.02.007","url":null,"abstract":"","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147366722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alternative pricing policies for multi-indication products: a quantitative analysis. 多指标产品的替代定价政策:定量分析。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-03 DOI: 10.1016/j.jval.2026.02.009
Beth S Woods, Carlos Rojas Roque, Claire Rothery, Mark Sculpher, Karl Claxton
{"title":"Alternative pricing policies for multi-indication products: a quantitative analysis.","authors":"Beth S Woods, Carlos Rojas Roque, Claire Rothery, Mark Sculpher, Karl Claxton","doi":"10.1016/j.jval.2026.02.009","DOIUrl":"https://doi.org/10.1016/j.jval.2026.02.009","url":null,"abstract":"","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147366725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond 'Today': Making Recall-Period Choices Clinically and Economically Meaningful. 超越“今天”:使回忆时期的选择具有临床和经济意义。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-03 DOI: 10.1016/j.jval.2026.02.008
Jinbang Huang, Wenyi Wu, Yuqiang Zhang, Shi Huang, Gang Deng
{"title":"Beyond 'Today': Making Recall-Period Choices Clinically and Economically Meaningful.","authors":"Jinbang Huang, Wenyi Wu, Yuqiang Zhang, Shi Huang, Gang Deng","doi":"10.1016/j.jval.2026.02.008","DOIUrl":"https://doi.org/10.1016/j.jval.2026.02.008","url":null,"abstract":"","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147366767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disinvestment and Health Spending Efficiency in Latin America and the Caribbean: A Case Study of Colombia 拉丁美洲和加勒比地区的撤资和卫生支出效率:以哥伦比亚为例。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-01 Epub Date: 2025-10-21 DOI: 10.1016/j.jval.2025.09.3069
Carolina Moreno-López MSc , Ramon Castano MD, PhD , Pamela Gongora-Salazar MSc, DPhil , Úrsula Giedion MSc , Ginna P. Saavedra MD, MSc , Andrés I. Vecino-Ortiz MSc, MD, PhD

Objectives

This study aims to measure and quantify the potential financial and health (opportunity cost) impact of disinvestment in 6 candidate health technologies in Colombia (cesarean delivery, preoperative chest x-ray, computed tomography scan for headaches with no warning signs, extended use of proton-pump inhibitors, antibiotics, and antihistamines in cold), identified by previous research.

Methods

We carried out a microcosting approach involving 4 steps: identifying required data, defining the baseline case for evaluation, estimating waste for each prioritized technology along with the potential financial impact of disinvestment, and quantifying the opportunity cost of reallocating these resources to selected cost-effective alternatives (best- buys), using different methodologies.

Results

Among the 6 technologies, inappropriate use of computed tomography scans generated the highest level of waste. If reallocated, these resources could enable 9029 additional women to receive 4 prenatal care visits, reducing the existing coverage gap by approximately 6.4%. Similar results are presented for other technologies.

Conclusions

Health systems in Latin America and the Caribbean (LAC) face financial pressures from rising healthcare costs, inflation, and limited economic growth. Strategic disinvestment can contribute to more sustainable health systems by rationalizing spending and improving health outcomes in Latin America and the Caribbean. This study showed the potential health effect of redirecting resources from wasteful or ineffective technologies to highly cost-effective interventions offering a practical pathway to narrow coverage gaps and improve health outcomes in the region.
拉丁美洲和加勒比(LAC)的卫生系统面临着医疗费用上升、通货膨胀和经济增长有限带来的财政压力。使不适当或不必要的技术使用合理化可以提高效率和可持续性,特别是当这些技术产生有限的利益或甚至可能导致潜在危害时。战略性撤资可以通过使支出合理化和改善拉丁美洲和加勒比地区的卫生结果,促进卫生系统的更可持续发展;然而,它在该地区的影响在很大程度上仍未得到检验。目的:本研究旨在衡量和量化哥伦比亚六种候选卫生技术(剖宫产、术前胸部x线、无预警迹象的头痛CT扫描、延长使用质子泵抑制剂、抗生素和感冒抗组胺药)的潜在财务和健康(机会成本)影响。方法:采用微观成本核算方法。涉及四个步骤:确定所需的数据,定义评估的基线案例,估计每个优先技术的浪费以及撤资的潜在财务影响,以及使用不同的方法将这些资源重新分配给选定的具有成本效益的替代方案(最合算)的机会成本。结果:在六种技术中,CT扫描使用不当产生的浪费最高。如果重新分配,这些资源可使另外9 029名妇女接受4次产前护理,将现有的覆盖面差距缩小约6.4%。其他技术也得到了类似的结果。结论:我们展示了将资源从浪费或无效的技术转向高成本效益的干预措施的潜在健康影响,为缩小覆盖差距和改善该地区的健康结果提供了切实可行的途径。
{"title":"Disinvestment and Health Spending Efficiency in Latin America and the Caribbean: A Case Study of Colombia","authors":"Carolina Moreno-López MSc ,&nbsp;Ramon Castano MD, PhD ,&nbsp;Pamela Gongora-Salazar MSc, DPhil ,&nbsp;Úrsula Giedion MSc ,&nbsp;Ginna P. Saavedra MD, MSc ,&nbsp;Andrés I. Vecino-Ortiz MSc, MD, PhD","doi":"10.1016/j.jval.2025.09.3069","DOIUrl":"10.1016/j.jval.2025.09.3069","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to measure and quantify the potential financial and health (opportunity cost) impact of disinvestment in 6 candidate health technologies in Colombia (cesarean delivery, preoperative chest x-ray, computed tomography scan for headaches with no warning signs, extended use of proton-pump inhibitors, antibiotics, and antihistamines in cold), identified by previous research.</div></div><div><h3>Methods</h3><div>We carried out a microcosting approach involving 4 steps: identifying required data, defining the baseline case for evaluation, estimating waste for each prioritized technology along with the potential financial impact of disinvestment, and quantifying the opportunity cost of reallocating these resources to selected cost-effective alternatives (best- buys), using different methodologies.</div></div><div><h3>Results</h3><div>Among the 6 technologies, inappropriate use of computed tomography scans generated the highest level of waste. If reallocated, these resources could enable 9029 additional women to receive 4 prenatal care visits, reducing the existing coverage gap by approximately 6.4%. Similar results are presented for other technologies.</div></div><div><h3>Conclusions</h3><div>Health systems in Latin America and the Caribbean (LAC) face financial pressures from rising healthcare costs, inflation, and limited economic growth. Strategic disinvestment can contribute to more sustainable health systems by rationalizing spending and improving health outcomes in Latin America and the Caribbean. This study showed the potential health effect of redirecting resources from wasteful or ineffective technologies to highly cost-effective interventions offering a practical pathway to narrow coverage gaps and improve health outcomes in the region.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 3","pages":"Pages 383-390"},"PeriodicalIF":6.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of China’s National Drug Price Negotiation Policy on Availability, Affordability, and Regional Equity of Negotiated Drugs: A Multidimensional Nationwide Analysis, 2018 to 2021 中国药品价格谈判政策对药品可及性、可负担性和区域公平的影响:2018 - 2021年全国多维分析
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-01 Epub Date: 2025-10-27 DOI: 10.1016/j.jval.2025.10.002
Yue Qiu PhD , Lanting Lyu PhD , Hongbin Yi MSc , Xiaotong Jiang MSc , Gezheng Zhao MPH , Bo Peng MSc , Jiahui Tan MSc , Weiyan Jian PhD , Yingyao Chen PhD , Jay Pan PhD

Objectives

Comprehensive evidence on nationwide impact of China’s National Reimbursement Drug List (NRDL) negotiation policy is lacking. This study is to assess the availability, affordability, and regional equity of negotiated drugs included in NRDL using nationally representative data.

Methods

This cross-sectional study utilized 3 drug databases: 2 nationwide databases in China (2018-2021 and 2019-2021) and 1 multinational database (2017-2022). We examined changes in 6 indicators for negotiated drugs added to the NRDL: proportion of procurement hospital and defined daily doses (DDDs) for availability; defined daily dose cost (DDDc), reimbursement proportion (RP), and drug price index (DPI) for affordability; and Gini coefficient for equity. Drugs were grouped depending on approval time, negotiation year, and status (new vs renewed listing) across the Anatomical Therapeutic Chemical (ATC) classification. We performed inter- and intragroup descriptive analyses to show trends over time and across categories. The DPI was compared with 10 countries.

Results

For availability, the proportion of procurement hospital increased by 0.89% to 53.44%, and DDDs grew substantially across all groups (compound annual growth rate [CAGR]:25.21%-26,700%). For affordability, DPI decreased from a mid-level among reference countries (10 other countries) in 2017 to the lowest in 2022. DDDc declined after negotiation (CAGR: −6.28% to −70.20%). Reimbursement proportion remained stable (62.40%-80.12%) from 2019 to 2021. Regional equity improved with most ATC classifications (60.66%) having a Gini coefficient below 0.4.

Conclusions

China’s NRDL negotiation policy has improved drug availability and affordability while ensuring geographic equity, although risks remain. This study offers insights for policy makers, particularly in low-accessibility countries, to refine drug pricing policies.
目的:缺乏关于国家药品目录(NRDL)谈判政策在全国范围内影响的综合证据。本研究旨在利用具有全国代表性的数据,评估NRDL中协商药品的可得性、可负担性和区域公平性。​我们检查了加入nrdl的协商药品的六个指标的变化——采购医院比例(PPH)和规定日剂量(DDDs)的可获得性;限定日剂量成本(DDDc)、报销比例(RP)和药品价格指数(DPI)的可负担性;基尼系数代表公平。药物根据批准时间、谈判年份和状态(新上市与更新上市)在解剖治疗化学(ATC)分类中进行分组。我们进行了组间和组内的描述性分析,以显示随时间和跨类别的趋势。结果:就可得性而言,PPH增加了0.89%至53.44%,DDDs在所有组中均大幅增长(复合年增长率:25.21%-26,700%)。在可负担性方面,DPI从2017年参考国家(其他10个国家)的中等水平下降到2022年的最低水平。DDDc在谈判后下降(复合年增长率:-6.28%至-70.20%)。RP在2019 - 2021年保持稳定(62.40%-80.12%)。区域公平得到改善,大多数ATC分类(60.66%)的基尼系数低于0.4。结论和相关性:中国的NRDL谈判政策在确保地域公平的同时提高了药品的可得性和可负担性,尽管风险仍然存在。这项研究为决策者,特别是低可及性国家的决策者完善药品定价政策提供了见解。
{"title":"Impact of China’s National Drug Price Negotiation Policy on Availability, Affordability, and Regional Equity of Negotiated Drugs: A Multidimensional Nationwide Analysis, 2018 to 2021","authors":"Yue Qiu PhD ,&nbsp;Lanting Lyu PhD ,&nbsp;Hongbin Yi MSc ,&nbsp;Xiaotong Jiang MSc ,&nbsp;Gezheng Zhao MPH ,&nbsp;Bo Peng MSc ,&nbsp;Jiahui Tan MSc ,&nbsp;Weiyan Jian PhD ,&nbsp;Yingyao Chen PhD ,&nbsp;Jay Pan PhD","doi":"10.1016/j.jval.2025.10.002","DOIUrl":"10.1016/j.jval.2025.10.002","url":null,"abstract":"<div><h3>Objectives</h3><div>Comprehensive evidence on nationwide impact of China’s National Reimbursement Drug List (NRDL) negotiation policy is lacking. This study is to assess the availability, affordability, and regional equity of negotiated drugs included in NRDL using nationally representative data.</div></div><div><h3>Methods</h3><div>This cross-sectional study utilized 3 drug databases: 2 nationwide databases in China (2018-2021 and 2019-2021) and 1 multinational database (2017-2022). We examined changes in 6 indicators for negotiated drugs added to the NRDL: proportion of procurement hospital and defined daily doses (DDDs) for availability; defined daily dose cost (DDDc), reimbursement proportion (RP), and drug price index (DPI) for affordability; and Gini coefficient for equity. Drugs were grouped depending on approval time, negotiation year, and status (new vs renewed listing) across the Anatomical Therapeutic Chemical (ATC) classification. We performed inter- and intragroup descriptive analyses to show trends over time and across categories. The DPI was compared with 10 countries.</div></div><div><h3>Results</h3><div>For availability, the proportion of procurement hospital increased by 0.89% to 53.44%, and DDDs grew substantially across all groups (compound annual growth rate [CAGR]:25.21%-26,700%). For affordability, DPI decreased from a mid-level among reference countries (10 other countries) in 2017 to the lowest in 2022. DDDc declined after negotiation (CAGR: −6.28% to −70.20%). Reimbursement proportion remained stable (62.40%-80.12%) from 2019 to 2021. Regional equity improved with most ATC classifications (60.66%) having a Gini coefficient below 0.4.</div></div><div><h3>Conclusions</h3><div>China’s NRDL negotiation policy has improved drug availability and affordability while ensuring geographic equity, although risks remain. This study offers insights for policy makers, particularly in low-accessibility countries, to refine drug pricing policies.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 3","pages":"Pages 391-402"},"PeriodicalIF":6.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145402078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Return-on-Investment in Health Economic Evaluation: An Exploratory Analysis 投资回报在卫生经济评价中的探索性分析。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-01 Epub Date: 2025-11-17 DOI: 10.1016/j.jval.2025.10.016
Mina Alizadehsadrdaneshpour PhD , Jacob Smith MA , Mike Paulden PhD , Eric Nauenberg PhD

Objectives

This article explores issues of methodological rigor and threshold development for return-on-investment (ROI) measures. Although economic evaluation methods such as cost-effectiveness, cost-utility analysis, and cost-benefit analyses have standard guidelines that allow for consistent comparison across studies, these are sorely missing with respect to ROI.

Methods

We use economic concepts of opportunity cost, Pareto optimality, and fairness to propose initial ROI threshold measures and help explore how guidelines for future calculation of these measures might be established.

Results

This article proposes an initial threshold of 0.08 for ROI calculations that monetize health benefits and −0.47 for those that fail to do so based on the economic concept of opportunity cost. This article also flags concern regarding the overall methodology for calculating ROI potentially resulting in suboptimal resource allocation and ethical concerns with bias in the way ROI measures may direct resources.

Conclusions

There are a number of methodological shortcomings with regard to ROI measures that partially explains the orders of magnitude greater variation observed in this measure compared with other economic evaluation measures when examining the full scope of health interventions. The establishment of thresholds and future guidelines for calculation should narrow this variation somewhat and help to avoid impinging upon Pareto optimality and fairness. Such modifications should help increase the utility of ROI measures in the future.
目的:本文探讨了投资回报率(ROI)措施的方法严谨性和阈值开发问题。虽然像成本效益、成本效用分析和成本效益分析这样的经济评估方法有标准的指导方针,允许在研究中进行一致的比较,但这些在ROI方面严重缺失。方法:我们采用机会成本、帕累托最优性和公平性等经济概念提出初始ROI阈值度量,并帮助探索如何建立该度量的未来计算指南。结果:本文提出了将健康福利货币化的ROI计算的初始阈值为0.08,而基于机会成本的经济概念,未货币化的ROI计算的初始阈值为-0.47。本文还标记了对计算ROI的总体方法的关注,该方法可能导致次优资源分配和道德问题,并在ROI测量可能直接指导资源的方式中存在偏见。结论:ROI测量在方法上存在一些缺陷,这部分解释了在检查卫生干预措施的全部范围时,与其他经济评估测量相比,在该测量中观察到的差异要大几个数量级。阈值的建立和未来计算指南应该在一定程度上缩小这种差异,并有助于避免冲击帕累托最优性和公平性。这样的修改应该有助于在将来增加ROI度量的效用。
{"title":"Return-on-Investment in Health Economic Evaluation: An Exploratory Analysis","authors":"Mina Alizadehsadrdaneshpour PhD ,&nbsp;Jacob Smith MA ,&nbsp;Mike Paulden PhD ,&nbsp;Eric Nauenberg PhD","doi":"10.1016/j.jval.2025.10.016","DOIUrl":"10.1016/j.jval.2025.10.016","url":null,"abstract":"<div><h3>Objectives</h3><div>This article explores issues of methodological rigor and threshold development for return-on-investment (ROI) measures. Although economic evaluation methods such as cost-effectiveness, cost-utility analysis, and cost-benefit analyses have standard guidelines that allow for consistent comparison across studies, these are sorely missing with respect to ROI.</div></div><div><h3>Methods</h3><div>We use economic concepts of opportunity cost, Pareto optimality, and fairness to propose initial ROI threshold measures and help explore how guidelines for future calculation of these measures might be established.</div></div><div><h3>Results</h3><div>This article proposes an initial threshold of 0.08 for ROI calculations that monetize health benefits and −0.47 for those that fail to do so based on the economic concept of opportunity cost. This article also flags concern regarding the overall methodology for calculating ROI potentially resulting in suboptimal resource allocation and ethical concerns with bias in the way ROI measures may direct resources.</div></div><div><h3>Conclusions</h3><div>There are a number of methodological shortcomings with regard to ROI measures that partially explains the orders of magnitude greater variation observed in this measure compared with other economic evaluation measures when examining the full scope of health interventions. The establishment of thresholds and future guidelines for calculation should narrow this variation somewhat and help to avoid impinging upon Pareto optimality and fairness. Such modifications should help increase the utility of ROI measures in the future.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 3","pages":"Pages 413-418"},"PeriodicalIF":6.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145557779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reversing Proxy Roles: Care Recipients as Proxies for Caregiver Health-Related Quality of Life 反向代理角色:照顾者作为照顾者健康相关生活质量的代理。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-03-01 Epub Date: 2025-11-17 DOI: 10.1016/j.jval.2025.10.012
Maja Kuharic PhD, MSc , Neo (Hsuanyun) Su PharmD , A. Simon Pickard PhD

Objectives

To evaluate the suitability of care recipients as proxies for assessing caregivers’ health-related quality of life (HRQL) using the EuroQol 5-Dimension 5-Level instrument (EQ-5D-5L).

Methods

A cross-sectional online survey of 504 US caregiver-patient dyads was conducted. Self and proxy versions of EQ-5D-5L and EuroQol Visual Analog Scale (EQ-VAS) were completed by both caregivers and care recipients. Agreement was evaluated using intraclass correlation coefficients (ICC), interpreted as poor (0-0.2), fair (0.2-0.4), moderate (0.4-0.6), substantial (0.6-0.8), and excellent (>0.8). Directional bias was assessed through mean differences between proxy and self-assessment score.

Results

Care-recipient proxy assessments showed fair-to-moderate agreement with caregiver self-assessments across EQ-5D-5L dimensions (ICC range: 0.37-0.55) and summary scores (EQ-5D-5L Index: ICC = 0.54, EQ-VAS: ICC = 0.57). Care recipients consistently overestimated caregivers’ HRQL across all dimensions, with the largest differences in usual activities and anxiety/depression (both mean difference = 0.24). The directional bias for the EQ-5D-5L Index showed systematic overestimation (mean difference = −0.06), with a small effect size (0.22). In comparison, caregivers showed higher agreement when assessing care recipients (ICC range: 0.59-0.82) with slight underestimation (mean difference = 0.03, effect size = 0.09). These patterns remained consistent across subgroup analyses.

Conclusions

Care recipients showed overestimation of caregiver HRQL, although the effect size was small. Although the agreement was lower than in traditional caregiver proxy assessments, the small magnitude of bias suggests that this approach could be valuable for group-level assessments. This method may offer a practical solution for capturing caregiver spillover effects in health technology assessments when direct caregiver assessment is challenging.
目的:利用EQ-5D-5L评估照护者健康相关生活质量(HRQL),评价照护者作为代理的适用性。方法:对504名美国护理者和患者进行横断面在线调查。照护者和受护者分别完成EQ-5D-5L和EQ-VAS的自我和代理版本。使用类内相关系数(ICC)评估一致性,解释为差(0-0.2),一般(0.2-0.4),中等(0.4-0.6),实质性(0.6-0.8)和优秀(>0.8)。通过代理评分与自评评分的平均差异来评估方向性偏倚。结果:在EQ-5D-5L维度(ICC范围:0.37-0.55)和总结分数(EQ-5D-5L指数:ICC=0.54, EQ-VAS: ICC=0.57)上,照护者代理评估与照护者自我评估具有相当到中等程度的一致性。照护者在所有维度上都高估了照护者的HRQL,在日常活动和焦虑/抑郁方面差异最大(两者的平均差异=0.24)。EQ-5D-5L指数的方向性偏倚表现为系统性高估(平均差值=-0.06),效应量较小(0.22)。相比之下,照顾者在评估被照顾者时表现出更高的一致性(ICC范围:0.59-0.82),轻微低估(平均差异=0.03,效应量=0.09)。这些模式在亚组分析中保持一致。结论:受照护者对照护者的HRQL有过高的估计,但效应量较小。虽然这种一致性低于传统的看护代理评估,但偏差的小幅度表明,这种方法对于群体水平的评估可能是有价值的。当直接护理人员评估具有挑战性时,这种方法可能为在卫生技术评估中捕捉护理人员溢出效应提供实用的解决方案。
{"title":"Reversing Proxy Roles: Care Recipients as Proxies for Caregiver Health-Related Quality of Life","authors":"Maja Kuharic PhD, MSc ,&nbsp;Neo (Hsuanyun) Su PharmD ,&nbsp;A. Simon Pickard PhD","doi":"10.1016/j.jval.2025.10.012","DOIUrl":"10.1016/j.jval.2025.10.012","url":null,"abstract":"<div><h3>Objectives</h3><div>To evaluate the suitability of care recipients as proxies for assessing caregivers’ health-related quality of life (HRQL) using the EuroQol 5-Dimension 5-Level instrument (EQ-5D-5L).</div></div><div><h3>Methods</h3><div>A cross-sectional online survey of 504 US caregiver-patient dyads was conducted. Self and proxy versions of EQ-5D-5L and EuroQol Visual Analog Scale (EQ-VAS) were completed by both caregivers and care recipients. Agreement was evaluated using intraclass correlation coefficients (ICC), interpreted as poor (0-0.2), fair (0.2-0.4), moderate (0.4-0.6), substantial (0.6-0.8), and excellent (&gt;0.8). Directional bias was assessed through mean differences between proxy and self-assessment score.</div></div><div><h3>Results</h3><div>Care-recipient proxy assessments showed fair-to-moderate agreement with caregiver self-assessments across EQ-5D-5L dimensions (ICC range: 0.37-0.55) and summary scores (EQ-5D-5L Index: ICC = 0.54, EQ-VAS: ICC = 0.57). Care recipients consistently overestimated caregivers’ HRQL across all dimensions, with the largest differences in usual activities and anxiety/depression (both mean difference = 0.24). The directional bias for the EQ-5D-5L Index showed systematic overestimation (mean difference = −0.06), with a small effect size (0.22). In comparison, caregivers showed higher agreement when assessing care recipients (ICC range: 0.59-0.82) with slight underestimation (mean difference = 0.03, effect size = 0.09). These patterns remained consistent across subgroup analyses.</div></div><div><h3>Conclusions</h3><div>Care recipients showed overestimation of caregiver HRQL, although the effect size was small. Although the agreement was lower than in traditional caregiver proxy assessments, the small magnitude of bias suggests that this approach could be valuable for group-level assessments. This method may offer a practical solution for capturing caregiver spillover effects in health technology assessments when direct caregiver assessment is challenging.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 3","pages":"Pages 441-448"},"PeriodicalIF":6.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145557694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Value in Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1